CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
(CLDN18.2)-positive, human epidermal growth factor receptor 2 (HER2)-negative, gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...
Phase 3
Louisville, Kentucky, United States and 229 other locations
(TPC) in participants with advanced/metastatic gastroesophageal adenocarcinoma. The primary hypothesis of this study is sacituzumab tirumote...
Phase 3
Louisville, Kentucky, United States and 167 other locations
esophageal adenocarcinoma.This substudy will have two phases: a safety lead-in phase and an efficacy phase. The safety lead-in phase will b...
Phase 1, Phase 2
Louisville, Kentucky, United States and 43 other locations
and capecitabine monotherapy in patients with metastatic pancreatic adenocarcinoma whose disease has not progressed on a first line fluoropy...
Phase 1, Phase 2
Louisville, Kentucky, United States and 15 other locations
the treatment of participants with advanced or metastatic gastric adenocarcinoma, gastroesophageal junction (GEJ) adenocarcinoma...
Phase 1, Phase 2
Louisville, Kentucky, United States and 43 other locations
first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...
Phase 3
Louisville, Kentucky, United States and 212 other locations
efficacy of Spevatamig (PT886). Patients with the following tumor types will be eligible for screening: unresectable or metastatic gastric adenocarcinoma...
Phase 1, Phase 2
Louisville, Kentucky, United States and 10 other locations
Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...
Phase 3
Louisville, Kentucky, United States and 5 other locations
in participants with untreated metastatic Pancreatic Ductal Adenocarcinoma (PDAC) with homozygous methylthioadenosine phosphorylase (MTAP) d...
Phase 2, Phase 3
Louisville, Kentucky, United States and 275 other locations
Zolbetuximab is being studied in people with cancer in and around the stomach or where the food pipe (esophagus) joins the stomach, called gastroesop...
Phase 3
Louisville, Kentucky, United States and 219 other locations
Clinical trials
Research sites
Resources
Legal